Recombinant Vector Vaccine Market was valued at USD 19.14 billion
Key Highlights The Recombinant Vector Vaccine Market was valued at US$ 19.14 billion in 2023. The market is expected to reach US$ 31.14 billion by 2030. Revenue is projected to grow at…
